Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Arsy Buana Travelindo Tbk. (HAJJ) vs Indofarma Tbk. (INAF) Price & Performance

Arsy Buana Travelindo Tbk.Trade
Indofarma Tbk.Trade

Price performance (Past 24H)

Key statistics

Arsy Buana Travelindo Tbk. vs Indofarma Tbk. — how do they compare? Arsy Buana Travelindo Tbk. trades at Rp112 (market cap 276.48B, 4.8M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Indofarma Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

HAJJINAF
Market Cap
276.48B390.51B
Volume
4.8M
Lot
48.03K
Turnover
535.28M
Average Price
111.44
Value
535.28M
Indicative Equilibrium Price
112
Indicative Equilibrium Volume
3

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HAJJ
View details
INAF
View details

About Arsy Buana Travelindo Tbk.

PT Arsy Buana Travelindo Tbk (the Entity) was established based on Notarial Deed No. 25 dated November 21, 2016 of Harra Mieltuani Lubis SH. The Entity started its commercial operations in 2018. PT Madinah Iman Wisata is the parent entity, whereas Entin Suryatin is the ultimate beneficial owner.

Read more on HAJJ

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF